Teladoc Health (TDOC) vs GeneDx (WGS)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Teladoc Health (TDOC) has outperformed GeneDx (WGS) over the past year, gaining 7.0% versus a loss of 69.0%. Over five years, WGS leads with a -80.0% price change compared with -93.2% for TDOC. GeneDx is the larger company by market cap ($1.36 billion vs $1.36 billion), about 1.0 times the size.
GeneDx converts more of its revenue into profit, with a net margin of -4.9% versus -7.9%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | TDOC | WGS |
|---|---|---|
| Share price | $7.45 | $45.46 |
| Market cap | $1.36B | $1.36B |
| 1-day change | -4.36% | -7.68% |
| YTD return | +6.43% | -65.05% |
| 1-year return | +7.04% | -68.98% |
| 5-year return | -93.20% | -80.01% |
| Forward P/E | — | 34.93 |
| EPS (TTM) | $-0.86 | $-3.76 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $2.53B | $427.54M |
| Revenue growth (YoY) | -1.54% | +39.97% |
| Net income (latest FY) | $-200.32M | $-21.02M |
| Gross margin | 69.50% | 69.74% |
| Operating margin | -10.39% | -3.06% |
| Net margin | -7.92% | -4.92% |
| 52-week high | $9.89 | $170.87 |
| 52-week low | $4.40 | $32.21 |
| Distance from 52-week high | -24.65% | -73.39% |
| Analyst consensus | hold | strong_buy |
| Avg. price target upside | +18.93% | +80.38% |
| Average volume | 4.24M | 869.34K |
| Shares outstanding | 182.29M | 29.97M |
| Employees | 4,648 | 1,300 |
| Sector | Health Care | Health Care |
| Industry | Medical/Nursing Services | Medical/Nursing Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- TDOC has outperformed WGS by 76.0 percentage points over the past year.
- GeneDx grew revenue faster in its latest fiscal year (+39.97% vs -1.54%).
About Teladoc Health
TDOC stock →Teladoc Health, Inc. provides virtual healthcare services worldwide.
Health Care · Medical/Nursing Services · 4,648 employees
About GeneDx
WGS stock →GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services.
Health Care · Medical/Nursing Services · 1,300 employees
TDOC vs WGS FAQ
Which is bigger, Teladoc Health or GeneDx?
GeneDx (WGS) is larger, with a market capitalization of $1.36B compared with $1.36B for Teladoc Health (TDOC).
Which stock has performed better over the past year, TDOC or WGS?
TDOC returned +7.04% over the past 12 months, compared with -68.98% for WGS (price return, excluding dividends). Past performance does not predict future results.
Are Teladoc Health and GeneDx in the same industry?
Yes. Both are classified in the Medical/Nursing Services industry within the Health Care sector.